AATF gene homepage

General information
Gene symbol AATF
Gene name apoptosis antagonizing transcription factor
Chromosome 17
Chromosomal band q12
Imprinted Unknown
Genomic reference NC_000017.11
Transcript reference NM_012138.3, XM_011524611.1
Associated with diseases -
Citation reference(s) -
Curators (0) -
Total number of public variants reported 0
Unique public DNA variants reported 0
Individuals with public variants 0
Hidden variants 0
Date created November 26, 2015
Date last updated December 16, 2015
Version AATF:151216

Links to other resources
HGNC 19235
Entrez Gene 26574
PubMed articles AATF
OMIM - Gene 608463
GeneCards AATF
GeneTests AATF

Active transcripts




NCBI ID     

NCBI Protein ID     

00065945 17 apoptosis antagonizing transcription factor NM_012138.3 NP_036270.1 0
00065946 17 transcript variant X1 XM_011524611.1 XP_011522913.1 0

Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective curator(s). Any unauthorised use, copying, storage or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2015-2022. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising out of any inaccuracies or omissions. Individuals, organisations and companies which use this database do so on the understanding that no liability whatsoever either direct or indirect shall rest upon the curator(s) or any of their employees or agents for the effects of any product, process or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.